yho-1701

anaplastic lymphoma kinase ; Mus musculus







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33758275 Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines. 2021 Mar 23 3